Magic mushroom compound may ease cancer pain without heavy drugs
NCT ID NCT06827054
First seen Nov 01, 2025 · Last updated May 20, 2026 · Updated 33 times
Summary
This study tests whether a low dose of psilocybin (a compound from magic mushrooms) combined with talk therapy is safe and helpful for easing chronic cancer pain in 20 adults who already take opioids. Participants will receive psilocybin in a supervised setting and undergo counseling to address the emotional and spiritual aspects of pain. The goal is to see if this approach can reduce pain intensity and improve well-being without major side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MALIGNANT SOLID NEOPLASM are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Roswell Park Cancer Institute
Buffalo, New York, 14263, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.